首頁 > 市場調查報告書 > 醫療設備

子宮內避孕器市場規模、佔有率和成長分析（按類型、產品類型、年齡層、應用和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898061

子宮內避孕器市場規模、佔有率和成長分析（按類型、產品類型、年齡層、應用和地區分類）—產業預測（2026-2033 年）

Intrauterine Contraceptive Devices Market Size, Share, and Growth Analysis, By Type (Hormonal Intrauterine Device, Copper Intrauterine Device), By Product Type (Mirena, Skyla), By Age Group, By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 195 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球子宮內避孕器 (IUD) 市場規模預計在 2024 年達到 46 億美元，從 2025 年的 48.1 億美元成長到 2033 年的 69 億美元，在預測期（2026-2033 年）內複合年成長率為 4.6%。

受計劃生育和生殖健康意識不斷提高的推動，全球子宮內避孕器（IUD）市場正經歷顯著成長。子宮內避孕器以其高效性和便利性而著稱，無需每日干預即可提供長期避孕保護。其價格合理且安全，吸引了不同年齡層的女性，加上政府和機構對孕產婦健康舉措的支持，共同推動了市場發展。無激素產品的需求不斷成長，以及提升用戶體驗的技術創新，也促進了市場成長。儘管文化差異和對安全性的誤解可能在某些地區阻礙子宮內避孕器的普及，但開發中國家醫療保健服務的普及正在創造新的機會。儘管面臨成本和來自其他避孕方法的競爭等挑戰，子宮內避孕器仍然是許多尋求可靠避孕方式的女性的首選。

全球子宮內避孕器市場按類型、產品類型、年齡層、最終用途和地區進行細分。依類型分類，子宮內避孕器分為含激素子宮內避孕器和含銅子宮內避孕器。依產品類型分類，子宮內避孕器分為曼月樂 (Mirena)、斯凱拉 (Skyra)、帕拉加德 (Paragard)、艾舒瑞 (Essure)、瑞沃塞特 (Revosert) 和其他產品。依年齡層別分類，子宮內避孕器分為 15-24 歲、25-34 歲、35-44 歲及 45 歲以上。依最終用途分類，子宮內避孕器分為醫院、婦科診所、社區健康中心和其他機構。按地區分類，子宮內避孕器分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球子宮內避孕器市場促進因素

全球子宮內避孕器市場主要受長效可逆避孕方法（LARC）需求成長的驅動，尤其是子宮內避孕器（IUD）。由於其避孕效果高、維護簡單且能提供長期避孕保護，越來越多的女性選擇這些方法。子宮內避孕器的避孕有效率超過99%，有效期限為3至10年，是短期避孕方法的便利替代方案。此外，醫療專業人員也擴大推薦這些長效可逆避孕方法作為第一線選擇，進一步促進了其普及。宣傳這些節育器益處和可靠性的宣傳活動不斷增加，有助於提高其在不同人群和地區的接受度。

壓制全球子宮內避孕器市場

由於文化和社會因素阻礙了子宮內避孕器的普及，全球市場面臨嚴峻的挑戰。儘管子宮內避孕器具有許多醫療益處，但由於人們對其安全性、對生育能力的影響以及放置過程中可能出現的不適感存在持續的誤解，許多地區仍然不願採用。避孕在不同文化中仍然是一個敏感話題，這使得女性難以獲得子宮內避孕器等有效的避孕方法。此外，對嚴重副作用的擔憂和宗教信仰的反對意見也進一步加劇了人們對子宮內避孕器的接受度。為了提高市場滲透率，進行有針對性的教育活動和社區宣傳計畫至關重要，這有助於提高人們對子宮內避孕器的認知，並促進猶豫不決的人群接受使用子宮內避孕器。

全球子宮內避孕器市場趨勢

全球子宮內避孕器市場正經歷著向非荷爾蒙避孕方式的顯著轉變，這主要得益於消費者對無荷爾蒙產品的偏好。隨著人們對荷爾蒙避孕潛在副作用的認知不斷提高，銅子宮內避孕器等產品在注重健康的女性中越來越受歡迎，她們尋求的是不會擾亂荷爾蒙平衡的長期解決方案。這一趨勢也推動了人們對舒適便捷的非侵入性避孕方式的需求成長。因此，製造商正不斷創新，以提升非荷爾蒙子宮內避孕器的吸引力和功能性，使其成為具有競爭力的替代方案，並正在重塑全球避孕市場的競爭格局。

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較
主要企業簡介
- 梯瓦製藥工業股份有限公司（耶路撒冷）
- 拜耳（德國）
- EUROGINE（西班牙）
- CooperSurgical Inc.（美國）
- 輝瑞公司（美國）
- HLL Lifecare Limited（特里凡得瑯）
- OCON Medical Ltd.（以色列）
- Prosan International BV（荷蘭）
- Melbea Innovations（匈牙利）
- 艾爾建，默克公司（美國）
- DKT國際（美國）
- Medisafe Distribution Inc.（加拿大）
- Medicines360（美國）
- Pregna International Limited（印度）
- 埃格門國際（土耳其）

結論與建議

簡介目錄

Product Code: SQMIG35A3009

Global Intrauterine Contraceptive Devices Market size was valued at USD 4.6 Billion in 2024 and is poised to grow from USD 4.81 Billion in 2025 to USD 6.9 Billion by 2033, growing at a CAGR of 4.6% during the forecast period (2026-2033).

The global market for Intrauterine Contraceptive Devices (IUDs) is experiencing significant growth driven by heightened awareness of family planning and reproductive health. IUDs are recognized for their effectiveness and low maintenance, providing extended pregnancy protection without daily attention. Their affordability and safety profile appeal to a diverse female demographic, further fueled by governmental and organizational support for maternal health initiatives. The rising demand for hormone-free options has also propelled the market, complemented by technological advancements that enhance user experience. While cultural resistance and myths concerning safety can hinder adoption, particularly in specified regions, the increasing access to healthcare in developing countries presents new opportunities. Despite challenges such as cost and competition from other contraceptives, IUDs remain a preferred choice for many women seeking reliable birth control solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intrauterine Contraceptive Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intrauterine Contraceptive Devices Market Segments Analysis

The Global Intrauterine Contraceptive Devices Market is segmented by Type, Product Type, Age Group, End Use and region. Based on Type, the market is segmented into Hormonal Intrauterine Device and Copper Intrauterine Device. Based on Product Type, the market is segmented into Mirena, Skyla, Paragard, Essure, Levosert and Others. Based on Age Group, the market is segmented into 15-24 years, 25-34 years, 35-44 years and Above 44 years. Based on End Use, the market is segmented into Hospitals, Gynecology Clinics, Community Health Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intrauterine Contraceptive Devices Market

The Global Intrauterine Contraceptive Devices market is significantly driven by the rising preference for long-acting reversible contraceptives, particularly intrauterine devices (IUDs). Women are increasingly choosing these options due to their high efficacy, minimal maintenance, and prolonged effectiveness in pregnancy prevention. With over 99% effectiveness and the ability to last between three to ten years, IUDs offer a convenient alternative to short-term contraceptives. Additionally, healthcare providers frequently recommend these long-acting reversible contraceptive methods as a primary option, further boosting their adoption. Enhanced awareness initiatives highlighting the advantages and reliability of these devices are fostering broader acceptance across diverse populations and regions.

Restraints in the Global Intrauterine Contraceptive Devices Market

The global market for intrauterine contraceptive devices faces significant challenges due to cultural and social factors that hinder their adoption. Despite their medical benefits, many regions remain hesitant to embrace IUDs, largely due to persistent misinformation regarding their safety, impact on fertility, and potential discomfort during insertion. In various cultures, contraception remains a sensitive topic, making it difficult for women to access effective birth control options like IUDs. Additionally, fears surrounding severe side effects and religious objections further complicate acceptance. To improve market penetration, targeted educational initiatives and community outreach programs are essential to raise awareness and enhance acceptance of IUDs among hesitant populations.

Market Trends of the Global Intrauterine Contraceptive Devices Market

The Global Intrauterine Contraceptive Devices market is experiencing a notable shift towards non-hormonal contraceptives, driven by an increasing consumer preference for hormone-free options. As awareness of potential side effects associated with hormonal birth control rises, products like the Copper IUD are gaining traction among health-conscious women seeking long-term solutions that do not disrupt hormonal balance. This trend underscores a growing appetite for non-invasive contraceptive methods that offer comfort and user-friendly designs. Consequently, manufacturers are innovating to enhance the appeal and functionality of non-hormonal IUDs, positioning them as competitive alternatives in the global contraceptive landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis
Customer & Buying Criteria Analysis

Global Intrauterine Contraceptive Devices Market Size by Type & CAGR (2026-2033)

Market Overview
Hormonal Intrauterine Device
Copper Intrauterine Device

Global Intrauterine Contraceptive Devices Market Size by Product Type & CAGR (2026-2033)

Market Overview
Mirena
Skyla
Paragard
Essure
Levosert
Others

Global Intrauterine Contraceptive Devices Market Size by Age Group & CAGR (2026-2033)

Market Overview
15-24 years
25-34 years
35-44 years
Above 44 years

Global Intrauterine Contraceptive Devices Market Size by End Use Industry & CAGR (2026-2033)

Market Overview
Hospitals
Gynecology Clinics
Community Health Care Centers
Others

Global Intrauterine Contraceptive Devices Market Size & CAGR (2026-2033)

North America (Type, Product Type, Age Group, End Use Industry)
- US
- Canada
Europe (Type, Product Type, Age Group, End Use Industry)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Product Type, Age Group, End Use Industry)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Product Type, Age Group, End Use Industry)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Product Type, Age Group, End Use Industry)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Teva Pharmaceutical Industries Ltd. (Jerusalem)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EUROGINE (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HLL Lifecare Limited (Thiruvananthapuram)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OCON Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prosan International BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Melbea Innovations (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan, Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DKT International (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medisafe Distribution Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medicines360 (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pregna International Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Egemen International (Turkey)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments